📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma. (2020)

First Author: Lyons Rimmer J

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers12071744

PubMed Identifier: 32629964

Publication URI: http://europepmc.org/abstract/MED/32629964

Type: Journal Article/Review

Volume: 12

Parent Publication: Cancers

Issue: 7

ISSN: 2072-6694